At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 243 enrolled
Drug / intervention
Edessy ICSI Outcome Embryo Scoreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Edessy ICSI Outcome Embryo Score (EIOS) Efficacy
In Brief
A Phase 2 clinical trial evaluating Edessy ICSI Outcome Embryo Score for Infertility. Completed, enrolled 243 participants across 1 site.
Detailed Summary
Purpose of this study is to detect outcome of intracytoplasmic sperm injection (ICSI) according to EIOS
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfertility
CountriesEgypt
Collaborators--
Timeline
Phase 2CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2010
Primary CompletionSep 2012
First PostedMar 2014
TodayJul 2026
First PostedMar 10, 2014
Enrollment StartDec 1, 2010
Primary CompletionSep 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 12.3 years ago
Interventions
Edessy ICSI Outcome Embryo Scoreother
EIOS: Age (ys) \>35 (0) 30-35 (1) \<30 (2) No of retrived oocyte \<5 (0) 5-9 (1) ≥ 10 (2) No of EC embryos \<2 (0) 2-4 (1) \>4 (2) No of good quality embryos \<3 (0) 3-5 (1) \>5 (2) No of embryos transferred -------- (0) ≤2 (1) \>2 (2)